CAR T-Cell therapy sends multiple myeloma into lasting remission – Science Daily
FierceBiotech |
CAR T-Cell therapy sends multiple myeloma into lasting remission
Science Daily CAR T-cell therapy is custom-made for each patient. The patient's own T cells are collected, genetically reprogrammed in a lab, and injected back into the patient. The reprogramming involves inserting an artificially designed gene into the T-cell … CAR T-cell therapy shows promise for patients with myeloma ASCO dark horse Nanjing Legend Biotech shines with promising CAR–T data Bluebird is pretty chirpy about its anti-BCMA CAR–T therapy results |
